找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Recent Advances in Prolactin Research; Maria Diakonova, PhD Book 2015 The Editor(s) (if applicable) and The Author(s), under exclusive lic

[复制链接]
楼主: Strategy
发表于 2025-3-26 21:51:40 | 显示全部楼层
发表于 2025-3-27 04:39:30 | 显示全部楼层
Prolactin-Induced Prostate Tumorigenesis,ors of the PRL signaling axis failed to identify an essential regulatory function on this tissue. However, a large body of evidence suggests an important role for PRL in prostate tumorigenesis. Mainly through the activation of its downstream target STAT5, PRL can induce growth and survival of prosta
发表于 2025-3-27 06:42:21 | 显示全部楼层
Prolactin in Inflammatory Response,pathways after binding to its receptor (PRLr) resulting in the activation of specific genes associated with the pleiotropic activities of PLR. To date, various PRLr isoforms have been described, generated by post-transcriptional or post-translational processes. PRL has been associated with the modul
发表于 2025-3-27 10:55:30 | 显示全部楼层
A Positive Feedback Loop Between Prolactin and Stat5 Promotes Angiogenesis,escribed that proangiogenic mediators such as fibroblast growth factors can activate members of the signal transducers and activators of transcription (STAT) family. STAT5 activation is necessary and sufficient to induce migration, invasion and tube formation of endothelial cells. STAT5 effects on e
发表于 2025-3-27 16:44:24 | 显示全部楼层
发表于 2025-3-27 21:10:38 | 显示全部楼层
发表于 2025-3-27 22:56:26 | 显示全部楼层
The Many Faces of Prolactin in Breast Cancer,gonist developed by introducing a single amino acid substitution mutation into human PRL (hPRL) at position 129, and a variety of G129R derivatives. The author has proposed two novel ideas for potential use of PRL, not anti-PRL agents, as an adjuvant agent for breast cancer, making it a hormone of many faces.
发表于 2025-3-28 03:34:39 | 显示全部楼层
Modeling Prolactin Actions in Breast Cancer In Vivo: Insights from the NRL-PRL Mouse,ndependent from ovarian steroids, and most are ER+. These characteristics resemble the human clinical disease, facilitating study of tumorigenesis, and identification of novel preventive and therapeutic approaches.
发表于 2025-3-28 09:02:45 | 显示全部楼层
发表于 2025-3-28 14:16:19 | 显示全部楼层
Regulation of Blood Vessels by Prolactin and Vasoinhibins, efficient mechanism for controlling blood vessel growth and function. This review briefly describes the vascular actions of PRL and vasoinhibins, and addresses how their interplay could help drive biological effects of PRL in the context of health and disease.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-22 23:31
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表